Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Rani Therapeutics Hldgs Q1 EPS $(0.22) Misses $(0.21) Estimate, Sales $172.00K

Author: Benzinga Newsdesk | May 13, 2025 04:33pm
Rani Therapeutics Hldgs (NASDAQ:RANI) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.21) by 4.76 percent. This is a 24.14 percent increase over losses of $(0.29) per share from the same period last year. The company reported $172.00 thousand in sales this quarter.

Posted In: RANI


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist